Prostate Cancer Clinical Trials in New York

Showing 141-160 of 223 trials

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

NCT04009083

This is a prospective outcomes study assessing quality of life and oncological control at pre-defined time points following FOCAL CRYO-ABLATION (FCA). The investigator's standard of care is to perform an Magentic Resonance Imaging (MRI) and prostate biopsy two years following FCA. The prostate biopsy assesses both the presence of in field and out of field disease. The role of Axumin PET/MRI for detecting disease following FCA has not been previously examined.

Prostate Cancer

NYU Langone Health31 participantsStarted Jun 2019

New York, New York, United States

COMPLETEDPHASE2< 1 mile

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

NCT00428714

The purpose is to see how quickly two different types of prostate cancer participants respond when taking enzastaurin. Cohort 1 - asymptomatic participants with androgen-independent prostate-specific antigen (PSA)-progressive disease without clinical or radiographic evidence of metastatic disease. Cohort 2 - participants with androgen-independent metastatic prostate cancer (documented bone or soft tissue metastases) with rising PSA, clinical, radiographic disease progression following one prior docetaxel-based regimen

Prostate Cancer

Eli Lilly and Company73 participantsStarted Jan 2007

Los Angeles, California, United States • Stanford, California, United States • New Haven, Connecticut, United States +8 more locations

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Prostate Cancer Trials in Other Cities

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Modifications to Radical Prostatectomy: Feasibility Study

ClariCore System Used in Transperineal Prostate Biopsy

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Genetic Analysis of Hereditary Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Analyses of Human Samples Collected in Clinical Trials

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Other Conditions in New York